Jason V. Baker, MD

Assistant Professor of Medicine, Division of Infectious Diseases and International Medicine

Jason V. Baker

Contact Info


Office Phone 612-624-9996

Fax 612-625-4410

Office Address:
Medicine - Infectious Disease
D416 Mayo
420 Delaware St SE
Minneapolis, MN 55455

Mailing Address:
Hennepin County Medical Center
Medicine Office
701 Park Avenue
Minneapolis, MN 55415

MD, University of Wisconsin, 2001

University of Minnesota

MS, University of Minnesota (Clinical Research), 2007

BS, University of Wisconsin, 1996

Oregon Health & Science University (Internal Medicine), 2004


Dr. Jason Baker is an Associate Professor of Medicine at the University of Minnesota and practices clinical Infectious Diseases and HIV Medicine at Hennepin County Medical Center (HCMC). Dr. Baker’s research program at HCMC involves translational clinical studies emphasizing persistent immune depletion, inflammation and coagulation abnormalities among HIV+ patients.He focuses on mechanisms and treatment strategies targeting aging complications, such as cardiovascular disease, through both pathogenesis oriented studies and multi-center trials and cohorts.Dr. Baker also holds leadership positions and directs studies within the NIH/NIAID-funded INSIGHT network (International Network for Strategic Initiative in Global HIV Trials), which recently conducted the SMART and START trials.


Research Summary/Interests

The pathogenosis of cardiovascular disease in HIV-infected patients, as well as the evaluation of prevention strategies of these patients.


  1. Baker JV, Peng G, Rapkin J, Abrams D, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD for the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). CD4+ cell count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008;22(7):841-848. (PMID: 18427202).
  2. Baker JV, Henry WK, Patel P, Bush TJ, Conley LJ, Mack WJ, Overton ET, Budoff M, Hammer J, Carpenter CC, Hodis HN, Brooks JT for the SUN Study Investigators. Progression of Carotid Intima-Media Thickness in a Contemporary HIV Cohort. Clinical Infectious Diseases 2011;53(8):826-835. (PMC3174096)
  3. Baker JV*, Brummel-Zeidens K*, Neuhaus J, Duprez D, Cummings N, Dalmau D, DeHovitz J, Lehman C, Sullivan A, Woolley I, Kuller L, Neaton JD and Tracy RP for the INSIGHT/SMART Study group. HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. Journal of AHA 2013;2:e000264
  4. Baker JV, Huppler Hullsiek K, Singh A, WilsonE, Henry WK, Lichtenstein K, Onen N, Kojic E, Patel P, Brooks JT, Hodis HN, Budoff M, and Sereti I for the CDC SUN Study Investigators. Immunologic Predictors of Coronary Artery Calcium Progression in a Contemporary HIV Cohort. AIDS 2014;28(6):831-40.
  5. Baker JV, Wyman Engen N, Huppler Hullsiek K, Stephan C, Jain MK, Munderi P, Pett S, Duprez D for the INSIGHT START Study Group. Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment trial. HIV Medicine 2015;S1:109-118.
  6. Longenecker CT, Sullivan C, Baker JV.Immune activation and cardiovascular disease in chronic HIV infection.Current Opinion in HIV/AIDS 2016;11(2):216-225
  7. Horvath K.J., Alemu D., Danh T., Baker J.V., and Carrico A. Creating Effective Smartphone Apps to Optimize ART Adherence: Perspectives from Stimulant-using HIV-positive Men who have Sex with Men. Journal of Medical Internet Research mHealth and uHealth 2016;4(2):e48(p1-11).
  8. Grund B, Baker JV, Deeks SG, Wolfson J, Wentworth D, Cozzi-lepri A, Cohen CJ, Phillips A, Lundgren JD, Neaton JD, for the INSIGHT SMART/ESPRIT/SILCAAT Study Group.Relevance of interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy.PLOS One 2016;11(5):e0155100